scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1050327670 |
P356 | DOI | 10.1186/S13741-016-0046-Z |
P932 | PMC publication ID | 4989364 |
P698 | PubMed publication ID | 27540479 |
P2093 | author name string | Peter Reinstrup | |
Karin Strandberg | |||
Martin Engström | |||
Caroline Ulfsdotter Nilsson | |||
P2860 | cites work | Fast interpretation of thromboelastometry in non-cardiac surgery: reliability in patients with hypo-, normo-, and hypercoagulability. | Q51304806 |
Early postoperative haematomas in neurosurgery. | Q53136886 | ||
A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients. | Q53158248 | ||
Development and clinical application of a new ELISA assay to determine plasmin-alpha2-antiplasmin complexes in plasma | Q71045282 | ||
Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study | Q74254051 | ||
Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion | Q24235742 | ||
Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis | Q26864678 | ||
Perioperative assessment of coagulability in neurosurgical patients using thromboelastography | Q28193879 | ||
Haemostatic changes during surgery for primary brain tumours | Q30495691 | ||
Post-operative hematoma after surgery for intracranial meningiomas: causes, avoidable risk factors and clinical outcome | Q33359641 | ||
Risk Factors for Postoperative Fibrinogen Deficiency after Surgical Removal of Intracranial Tumors | Q35866808 | ||
FIBTEM provides early prediction of massive transfusion in trauma | Q36073037 | ||
Prevention of venous thromboembolism in neurosurgery: a metaanalysis | Q37221941 | ||
Hemostatic and hemorrhagic problems in neurosurgical patients | Q37532001 | ||
Perioperative coagulation monitoring | Q37733476 | ||
Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review | Q37944502 | ||
Biology of Factor XIII and clinical manifestations of Factor XIII deficiency | Q38038687 | ||
Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: a randomized, placebo-controlled, multicenter clinical trial | Q38448997 | ||
Fluids and coagulation | Q38535463 | ||
Fibrinogen but not factor XIII deficiency is associated with bleeding after craniotomy | Q39185175 | ||
Brain tumors enhance plasmatic coagulation: the role of hemeoxygenase-1. | Q39274682 | ||
Thromboembolic diseases: biochemical mechanisms and new possibilities of biological diagnosis | Q41112756 | ||
Intra-operative hydroxyethyl starch is not associated with post-craniotomy hemorrhage | Q41554569 | ||
Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders | Q43006502 | ||
Mechanisms of hydroxyethyl starch-induced dilutional coagulopathy | Q45884984 | ||
Flurbiprofen and hypertension but not hydroxyethyl starch are associated with post-craniotomy intracranial haematoma requiring surgery | Q46145630 | ||
But is it safe? Hydroxyethyl starch in perioperative care | Q47745832 | ||
Stroke volume-directed administration of hydroxyethyl starch (HES 130/0.4) and Ringer’s acetate in prone position during neurosurgery: a randomized controlled trial | Q47966657 | ||
Serial changes in hemostasis after intracranial surgery | Q48099892 | ||
Abnormal coagulation profile in brain tumor patients during surgery | Q48160286 | ||
Perioperative assessment of coagulation in paediatric neurosurgical patients using thromboelastography | Q48433782 | ||
Hemostatic changes in pediatric neurosurgical patients as evaluated by thrombelastograph | Q48774599 | ||
Coagulation alterations in patients undergoing elective craniotomy | Q48823814 | ||
Counter statement to open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation | Q49063369 | ||
Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures | Q49151182 | ||
Use and utility of preoperative hemostatic screening and patient history in adult neurosurgical patients. | Q50517049 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | neurosurgery | Q188449 |
P304 | page(s) | 20 | |
P577 | publication date | 2016-08-17 | |
P1433 | published in | Perioperative medicine (London, England) | Q27725204 |
P1476 | title | Coagulation during elective neurosurgery with hydroxyethyl starch fluid therapy: an observational study with thromboelastometry, fibrinogen and factor XIII | |
P478 | volume | 5 |
Q57160255 | Comparison of dextran and albumin on blood coagulation in patients undergoing major gynaecological surgery |
Q90109366 | Low-Dose, Early Fresh Frozen Plasma Transfusion Therapy After Severe Trauma Brain Injury: A Clinical, Prospective, Randomized, Controlled Study |
Q93194693 | The Relationship Between Colloid Transfusion During Surgical Decompression Hemicraniectomy Period and Postoperative Pneumonia or Long-Term Outcome After Space-Occupying Cerebral Infarction: A Retrospective Study |
Search more.